Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-07-11
2006-07-11
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C540S049000
Reexamination Certificate
active
07074779
ABSTRACT:
The present invention is directed to novel estrieno[3,2-b]/[3,4-c]pyrrole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and diseases mediated by an estrogen receptor.
REFERENCES:
patent: 5726186 (1998-03-01), Grese
patent: 6004971 (1999-12-01), Grese
patent: 6133288 (2000-10-01), Grese
patent: 6262270 (2001-07-01), Draper et al.
patent: 0761669 (2000-11-01), None
patent: WO 97/09044 (1997-03-01), None
patent: WO 01/01969 (2001-01-01), None
Clinton, R.O. et al.: “Communications to the Editor. Steroidal [2,3-d]isoxezoles”. Journal of Organic Chemistry, Jan. (1961), 26, p. 279. Sterling-Winthrop Research Institute, New York.
Ackerman, J.H. et al.: “Steroidal Heterocycles. X. Sterodial[3,2d]pyrimidines and Related Compounds”. Sterling-Winthrop Research Institute, New York, Journal of Medical Chemistry, vol. 7, (1964), pp. 238-240.
Albert, J.L. et al.: “Estrogen Regulation of Placental Alkaline Phosphatase Gene Expression in a Human Endometrial Adenocarcinoma Cell Line”. Cancer Research, (50), pp. 3306-3310, Jun. 1, 1990.
Allan, G.F. et al.: “An Ultrahigh-Throughput Screening Assay for Estrogen Receptor Ligands”. Analytical Biochemistry vol. 275, pp. 243-247, (1999).
Clinton, R.O. et al.: “Steroidal[3,2-c]pyrazoles. II. Androstanes, 19-Norandrostanes and their Unsaturated Analogs”. Journal of American Chemical Society, (1961), 83, pp. 1478-1491. Sterling Winthrop Research Institute, New York.
Gupta, R. et al.: “Synthesis and Biological Activity of Azasteroidal [3,2-c] and [17, 16-c]pyrazoles”. European Journal of Medical Chemistry, (1996), 31, pp. 241-247.
Hirschmann, R. et al.: “Synthesis and Structure of Steroidal Pregn-4-eno-and 5 a-Pregano [3,2-c]pyrazoles. A Novel class of Potent Anti-Inflammatory Steroids”. Journal of American Chemical Society, (1964), 86, pp. 1520-1527.
Laitonjam, W.S. et al.: “Synthesis of some A- and D-ring Fused Steroidal Pyrazoles, Isoxazoles and Pyrimidines”. Steroids (2002), 67, pp. 203-209.
Manson, A.J. et al.: “Steroidal Heterocycles. VII. Androstano[2,3-d]isozazoles and Related Compounds” Journal of Medicinal Chemistry (1963) 8, No. 1, pp. 1-9.
Radu, I. et al.: “New Efficient Pathway for the Synthesis of 3-Aminoestrone”, Tetrahedron Letters (2002), 43, pp. 7617-7619.
Rottlander, M. et al.: “Palladium-Catalyzed Cross-Coupling Reactions with Aryl Nonaflates: A Practical Alternative to Aryl Triflates” (1998), 63, pp. 203-208.
Weidner, J.J. et al: “Preparation of N-Aryl-2-hydroxypropionamides from Hydroxy Aromatic Compounds Using a One-Pot Smiles Rearrangement Procedure.” Tetrahedron, (1997), 53, No. 18, pp. 8303-8312.
Welshons, W.V.: “Stimulation of breast cancer cells in vitro by the environmental enterolactone and the phytoestrogen equol”. Breast Cancer Research and Treatment 10, (1987), pp. 169-175.
Sui Zhihua
Zhang Xuqing
Badio Barbara P.
Ortho-McNeil Pharmaceutical , Inc.
LandOfFree
Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3528465